13 Mar, 2018 10:39 AM
Melbourne, Australia, 13 March 2018: Sienna Cancer Diagnostics Ltd (ASX:SDX), a commercial stage, medical technology company focused on the development and commercialisation of innovative cancer- rela...read more
19 Feb, 2018 09:58 AM
Melbourne, Australia, 19 February 2018: Sienna Cancer Diagnostics Ltd, (ASX:SDX), a commercial stage, medical technology company focused on the development and commercialisation of innovative cancer-r...read more
08 Nov, 2017 10:57 AM
An abstract discussing the results of a study performed by researchers at Johns Hopkins Hospital in Baltimore, USA, has been accepted by the United States and Canadian Academy of Pathology (USCAP) for...read more
18 Oct, 2017 11:51 AM
18 October 2017 - Melbourne, Australia. Sienna Cancer Diagnostics Ltd (“Sienna” or “the Company”), (ASX:SDX), a commercial stage medical technology company focused on the devel...read more
25 Sep, 2017 01:15 PM
25-Sep-2017
Melbourne, Australia, 25 September 2017: Sienna Cancer Diagnostics, a commercial stage, medical technology company focused on the development and commercialisation of innovative cancer-...read more
31 Aug, 2017 03:26 PM
Highlights
- Revenue from product sales up 25% to $804k, total revenue $1.46 million
- Revenue growth driven by sales of new IVD test through distribution partner StatLab, in first four months s...read more